Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
1.220
-0.070 (-5.43%)
At close: Jun 13, 2025, 4:00 PM
1.211
-0.009 (-0.73%)
After-hours: Jun 13, 2025, 6:34 PM EDT
Werewolf Therapeutics Market Cap
Werewolf Therapeutics has a market cap or net worth of $54.75 million as of June 13, 2025. Its market cap has decreased by -75.25% in one year.
Market Cap
54.75M
Enterprise Value
-282.15K
1-Year Change
-75.25%
Ranking
Category
Stock Price
$1.22
Market Cap Chart
Since the IPO on April 30, 2021, Werewolf Therapeutics's market cap has decreased from $440.42M to $54.75M, a decrease of -87.57%. That is a compound annual growth rate of -39.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 54.75M | -16.99% |
| Dec 31, 2024 | 65.95M | -52.79% |
| Dec 29, 2023 | 139.70M | 121.66% |
| Dec 30, 2022 | 63.03M | -80.81% |
| Dec 31, 2021 | 328.47M | -25.42% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.57B |
| Johnson & Johnson | 377.99B |
| Novo Nordisk | 355.28B |
| AbbVie | 337.52B |
| UnitedHealth Group | 284.42B |
| Abbott Laboratories | 235.96B |
| Novartis AG | 234.52B |
| AstraZeneca | 231.58B |